Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187876 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Biocleanse Allografts For ACL Reconstruction
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 67
- Enrollment target
NCT00187876 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 67 participants.
The verdict
NCT00187876, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of patellar tendon allografts that have undergone the BioCleanse™ process.
Interventions
- PROCEDURE ACL reconstruction control
- PROCEDURE ACL Biocleanse, surgical
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2004-02 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187876
The ClinicalTrials.gov registry entry for NCT00187876 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ACL reconstruction control is the first listed.
NCT00187876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187876 about?
NCT00187876 is a clinical study titled "Evaluation of Biocleanse Allografts For ACL Reconstruction". The purpose of this study is to determine the efficacy of patellar tendon allografts that have undergone the BioCleanse™ process.
What is the current status of trial NCT00187876?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 67 participants. The study started on 2004-02. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00187876?
The interventions under investigation include: ACL reconstruction control (PROCEDURE), ACL Biocleanse, surgical (PROCEDURE).
Who is sponsoring clinical trial NCT00187876?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.